F-01
Pre-Anesthesia Assessment & Pre-Induction Form
دليل السياسات والإجراءات في التخدير — Section M

Pre-Anesthesia Comprehensive Assessment & Optimization

Anesthesia Department - CBAHI/JCI Compliant

Patient Addressograph
(Name, MRN, DOB)
SECTION 1: PATIENT DEMOGRAPHICS & VITAL SIGNS
Date of Assessment: Age: yrs Gender: M F Height: cm Weight: kg BMI: kg/m²
Planned Procedure: Urgency: Elective Urgent Emergency
Surgeon/Service: Scheduled Date:
BP: ___/___ mmHg HR: ___ bpm RR: ___ /min SpO2: ___ % (RA) Temp: ___ °C   BSL: ___ mg/dL
SECTION 2: ALLERGIES & ADVERSE REACTIONS
NO KNOWN DRUG ALLERGIES (NKDA)     ALLERGIES PRESENT (Complete table below)
Allergen / Drug Type of Reaction Severity Details / Management
Rash/Anaphylaxis/GI/Other Mild/Moderate/Severe
Latex Allergy? No Yes → Latex-free setup required Food Allergies? No Yes: _______________________
SECTION 3: CURRENT MEDICATIONS & HERBAL SUPPLEMENTS
Medication Name Dose Frequency Indication Last Dose Taken Peri-Op Plan
Continue Hold
Continue Hold
Continue Hold
Continue Hold
Continue Hold
Continue Hold
Anticoagulation/Antiplatelet Therapy:
Warfarin (held ___ days) INR: ___ Aspirin (held ___ days) Clopidogrel/Plavix (held ___ days)
Rivaroxaban/NOAC (held ___ days) Heparin/LMWH (held ___ hrs) None
Herbal/Supplements: None Yes: ___________________________________ (Held ≥7 days?)
SECTION 4A: CARDIOVASCULAR SYSTEM REVIEW
Condition Details / Severity / Control / Medications
Hypertension (HTN) Control: Well Poorly | Meds: __________________________ | BP Today: ___/___
Coronary Artery Disease (CAD) Stable: Y N | Last MI: _______ | Angina: Y N | CCS Class: I/II/III/IV
Previous MI / ACS Date: __________ | Stent: BMS DES None | On DAPT: Y N
Congestive Heart Failure (CHF) NYHA Class: I/II/III/IV | EF: ____% | Type: HFrEF HFpEF | Last Echo: _______
Valvular Heart Disease Type: AS AR MS MR | Severity: Mild/Mod/Severe | Details: __________
Arrhythmia Type: AFib AFL VT SVT Other: _________ | On anticoag? _______
Pacemaker / ICD / AICD Type: __________ | Date implanted: _________ | Indication: _____________ | Last interrogation: _______
Peripheral Vascular Disease Claudication Rest pain Amputation | Stents/Grafts: __________________
Congenital Heart Disease Type: _________________________ | Corrected: Y N | Details: ______________
Pulmonary Hypertension PA Pressure: _____ mmHg | On therapy: Y N | Drugs: _______________________
Functional Capacity: ≥4 METS (Good) <4 METS (Poor) | Can climb 2 flights? Y N
Cardiac Risk: Low Intermediate High | RCRI Score: ____ | Cardiac consult needed? Y N
SECTION 4B: RESPIRATORY SYSTEM REVIEW
Condition Details / Severity / Control / Medications
Asthma Control: Well Poorly | Inhaler: __________ | Last attack: ________ | Ever intubated? Y N
COPD / Emphysema Severity: Mild/Mod/Severe | FEV1: ____% | Home O2: Y N ___L/min | Exacerbations/yr: ____
Obstructive Sleep Apnea (OSA) Diagnosed: Y Suspected | CPAP/BiPAP: Y N Settings: _____ | STOP-BANG: ____/8
Recent URTI (last 2 weeks) Resolved Active symptoms | Symptoms: _______________________ | Postpone? Y N
Pneumonia / Bronchitis Recent: Y N Date: ________ | Hospitalized? Y N | Resolved? Y N
Tuberculosis (TB) Status: Active Treated Old TB | On treatment: Y N | Precautions needed: _____
Restrictive Lung Disease Type: ILD Fibrosis Other: __________ | TLC: ____% | DLCO: ____%
Smoking History Status: Current Former (quit: _____) Never | Pack-years: _____ | Quit ≥8 weeks? _____
Dyspnea on Exertion Onset at: Rest Minimal Moderate Severe exertion | Orthopnea: Y N
Baseline O2 requirement: Room Air O2 at ___L/min via __________ | SpO2 today: ____%
Pulmonary Risk: Low Moderate High | Post-op respiratory plan: ____________________
SECTION 4C: NEUROLOGICAL & MUSCULOSKELETAL SYSTEM
Condition Details / Medications / Baseline Status
Stroke / TIA / CVA Date: _________ | Residual deficit: Y N Details: ______________ | On anticoag: _______
Seizure Disorder / Epilepsy Type: _________ | Frequency: ________ | Last seizure: ________ | Medications: ____________ | Controlled: Y N
Dementia / Cognitive Impairment Type: Alzheimer's Vascular Other | Baseline: _______ | Consent capacity: Y N
Parkinson's Disease Duration: _____ yrs | Medications: _________________ | Timing critical: Y N | Dysphagia: Y N
Multiple Sclerosis (MS) Type: RRMS PPMS | Last relapse: ________ | Medications: ______________ | Autonomic issues: Y N
Spinal Cord Injury Level: _____ | Complete/Incomplete | Autonomic dysreflexia risk: Y N | Baseline motor/sensory: ______
Back Problems / Spine Surgery Level: _________ | Hardware present: Y N | Chronic pain: Y N | Regional contraindication: Y N
Muscular Dystrophy / Myopathy Type: ________________________ | Cardiac involvement: Y N | Resp muscle weakness: Y N
Rheumatoid Arthritis (RA) C-spine involvement: Y N | TMJ limitation: Y N | Airway concern: Y N | Medications: ______
Myasthenia Gravis Thymectomy: Y N | Medications: ____________ | Recent crisis: Y N | Resp weakness: Y N
SECTION 4D: ENDOCRINE, RENAL & HEPATIC SYSTEM
Condition Details / Control / Medications
Diabetes Mellitus Type: 1 2 | Duration: ___yrs | HbA1c: ___% (Date: ___) | Insulin: Y N | Oral agents: _________
Diabetic Complications Neuropathy Nephropathy Retinopathy CAD Gastroparesis Autonomic
Thyroid Disease Hypothyroid Hyperthyroid | TSH: ____ (Date: ___) | Medications: _________ | Goiter: Y N
Adrenal Insufficiency Primary Secondary | On steroids: Y N Dose: ______ | Stress dose plan: __________
Chronic Steroid Use Duration: ______ | Current dose: _______ mg/day | Indication: ______________ | Stress dose needed: Y N
Chronic Kidney Disease (CKD) Stage: I/II/III/IV/V | Creatinine: ____ | eGFR: ____ | On dialysis: Y N Type: HD/PD | Last: _____
Renal Transplant Date: ________ | Baseline Cr: ____ | Immunosuppression: _________________ | Rejection episodes: Y N
Liver Disease / Cirrhosis Etiology: _________ | Child-Pugh: A/B/C | MELD: ____ | Ascites: Y N | Varices: Y N
Hepatitis (B / C / Other) Type: _______ | Active: Y N | Viral load: _______ | On treatment: Y N | Precautions: _____
GERD / Hiatal Hernia Severity: Mild/Mod/Severe | Medications: __________ | Aspiration risk: Low High | RSI needed: Y N
SECTION 4E: HEMATOLOGY, ONCOLOGY & INFECTIOUS DISEASE
Condition Details / Current Status / Treatment
Anemia Type: ___________ | Hb: ____ g/dL | Chronic: Y N | Transfusion history: _____ | Threshold: ____
Bleeding Disorder Type: Hemophilia vWD ITP Other: _______ | Factor level: ____ | Hematology consult: Y N
Sickle Cell Disease Type: SS SC Trait | Last crisis: ________ | Baseline Hb: ____ | Transfusion plan: _________
Thrombophilia / DVT/PE History Type: _____________ | Date: _______ | IVC filter: Y N | Anticoag: _______ | Duration: ________
Malignancy / Cancer Type: ____________ | Stage: _____ | Active treatment: Y N | Chemo/RT: _______ (Last: ___) | Remission: Y N
Chemotherapy History Agents: ________________ | Cardiotoxic: Y N | Pulm toxic: Y N | Last cycle: ________
Radiation Therapy Site: ___________ | Date: ________ | Airway/Neck radiation: Y N | Fibrosis concerns: Y N
HIV / AIDS CD4: _____ | Viral load: ________ | On HAART: Y N | Opportunistic infections: __________
COVID-19 History Date: ________ | Severity: Mild/Mod/Severe | Hospitalized: Y N | Residual symptoms: ___________
SECTION 4F: PSYCHIATRIC, OBSTETRIC & OTHER SYSTEMS
Condition Details / Medications / Management
Psychiatric Disorder Type: Depression Anxiety Bipolar Schizophrenia | Meds: _________ | Stable: Y N
Substance Abuse / Dependence Type: Alcohol Opioids Other: _______ | Active: Y N | Last use: _____ | Tolerance issues
Chronic Pain / Opioid Use Duration: ______ | Daily opioid: _______ mg OME | Tolerance: Y N | Pain management plan: _________
Pregnancy (if female) Currently pregnant: Y N | Weeks: ____ | LMP: _______ | Pregnancy test: Pos Neg N/A
Obesity / Metabolic Syndrome BMI: _____ kg/m² | Class I II III | OSA: Y N | Positioning issues: Y N
SECTION 5: PREVIOUS ANESTHESIA & FAMILY HISTORY
Previous Anesthesia / Surgery? No Yes (Details below)
Date Procedure Type of Anesthesia Complications
Anesthesia-Specific Complications:
Difficult intubation / airway
Prolonged PACU stay / delayed emergence
PONV (severe)
Awareness under anesthesia
Aspiration
Prolonged paralysis (succinylcholine)
Local anesthetic toxicity
Neuraxial complications (PDPH, epidural hematoma)
Other: _______________________________
FAMILY HISTORY OF ANESTHESIA COMPLICATIONS:
Malignant Hyperthermia (MH)? No Yes Unknown
Details / Relative: ____________________________
Pseudocholinesterase Deficiency? No Yes Unknown
Details: _______________________________________
Other familial anesthesia problems: _____________________________________________________
SECTION 6: SOCIAL HISTORY & SUBSTANCE USE
Tobacco:
Never smoker
Current: ___ cigarettes/day
Former: Quit _____ ago
Pack-years: ______
Alcohol:
None
Social (drinks/week): ___
Heavy use
History of withdrawal
CIWA protocol needed: Y N
Recreational Drugs:
None
Marijuana
Cocaine
Opioids (non-prescribed)
Other: ___________
Last use: ____________
SECTION 7: COMPREHENSIVE AIRWAY ASSESSMENT
Parameter Findings
Mallampati Classification Class I Class II Class III Class IV
Mouth Opening (Inter-incisor distance) ≥3 cm (Normal) <3 cm (Limited): _____ cm
Thyromental Distance (TMD) ≥6 cm (Normal) <6 cm (Short): _____ cm
Neck Mobility / Extension Full (Normal) Limited Fixed / Collar
Dentition Good Loose teeth Caps/Crowns Dentures (removed) Edentulous
Facial Hair / Beard None Present (may affect mask ventilation)
Jaw / TMJ Pathology Normal Receding mandible TMJ limitation Micrognathia
Neck Anatomy Normal Short neck Bull neck Thick neck (circumference: ___cm)
Airway Masses / Pathology None Goiter Tumor Abscess Stridor Other: _________
Previous Airway Surgery None Tracheostomy Neck dissection Radiation Other: ________
DIFFICULT AIRWAY PREDICTED? NO YES
Difficult Mask Ventilation? NO YES
Difficult Laryngoscopy? NO YES
If YES, Plan:
Awake fiberoptic intubation
Video laryngoscopy
LMA / Supraglottic device
Difficult airway cart ready
ENT backup / Surgical airway
Other: ___________________
SECTION 8: LABORATORY & DIAGNOSTIC INVESTIGATIONS
Test Result Date Normal Range Action if Abnormal
Hemoglobin (Hb) _____ g/dL _________ M: 13-17 / F: 12-15 Optimize Transfuse OK
Hematocrit (Hct) _____ % _________ M: 40-50 / F: 36-44
Platelets (Plt) _____ x10³ _________ 150-400 Consult Transfuse OK
White Blood Cells (WBC) _____ x10³ _________ 4-11 Investigate OK
INR _____ _________ 0.8-1.2 Reverse Delay OK
PTT / aPTT _____ sec _________ 25-35 Investigate OK
Sodium (Na) _____ mmol/L _________ 135-145 Correct OK
Potassium (K) _____ mmol/L _________ 3.5-5.0 Correct urgently OK
Creatinine (Cr) _____ mg/dL _________ 0.6-1.2 eGFR: ____ OK
Blood Urea Nitrogen (BUN) _____ mg/dL _________ 7-20
Glucose (Random) _____ mg/dL _________ 70-140 Diabetic protocol OK
HbA1c (if diabetic) _____ % _________ <7% Optimize if >8% OK
Pregnancy Test (β-hCG) Pos Neg _________ N/A if male/post-menopausal Consult OB if positive
Diagnostic Test Done? Findings / Interpretation
ECG (Electrocardiogram) Yes N/A Date: _______ | Normal Abnormal: _________________________________
Chest X-Ray (CXR) Yes N/A Date: _______ | Normal Abnormal: _________________________________
Echocardiogram (TTE/TEE) Yes N/A Date: _______ | EF: ____% | Valves: __________ | Other: _______________________
Pulmonary Function Tests (PFTs) Yes N/A Date: _______ | FEV1: ____% | FVC: ____% | Pattern: ____________________________
Stress Test / Cardiac Cath Yes N/A Date: _______ | Result: __________________________________________________________
Other (CT/MRI/US) Yes N/A Type: _______ Date: _______ | Findings: _________________________________________
SECTION 9: ASA CLASSIFICATION & RISK STRATIFICATION
ASA Physical Status:
ASA I - Normal healthy patient
ASA II - Mild systemic disease
ASA III - Severe systemic disease
ASA IV - Severe systemic disease that is constant threat to life
ASA V - Moribund patient not expected to survive without operation
ASA VI - Declared brain-dead patient whose organs are being removed for donor purposes
E - Emergency surgery (add E to classification)
Functional Capacity (METs):
≥4 METS (Good - climb 2 flights)
<4 METS (Poor - limited activity)
Unable to assess

Cardiac Risk (RCRI Score): ___/6
High-risk surgery, IHD, CHF, CVD, DM on insulin, Cr>2
Risk: Low Intermediate High
Pulmonary Risk Assessment:
Low risk
Moderate risk (COPD/Asthma/OSA)
High risk (FEV1 <50%, Hypercapnia)
Post-op respiratory support needed: Y N
Bleeding / Transfusion Risk:
Low (<500ml expected)
Moderate (500-1500ml expected)
High (>1500ml or MTP risk)
Blood products: G&S Cross-match ___ units
SECTION 10: ANESTHESIA PLAN & OPTIMIZATION
PROPOSED ANESTHESIA TECHNIQUE:
Primary Plan:
General Anesthesia (GA)
    GETA (Endotracheal)
    LMA / Supraglottic device
    RSI (Rapid Sequence)
Regional Anesthesia
    Spinal
    Epidural
    Combined Spinal-Epidural (CSE)
    Peripheral Nerve Block: ____________
MAC / Conscious Sedation
Combined Technique (GA + Regional)
Monitoring & Vascular Access:
Standard ASA monitors
Arterial line (A-line)
Central venous catheter (CVC)
Pulmonary artery catheter (PAC)
Cardiac output monitoring (FloTrac/PiCCO)
TEE (Transesophageal Echo)
Neuromonitoring (SSEP/MEP)
BIS / Depth of anesthesia monitor
Blood gas / Lab access

IV Access: ___ peripheral lines (gauge: ___)
Special equipment: ____________________
POST-OPERATIVE DISPOSITION:
PACU (Post-Anesthesia Care Unit)
ICU / Critical Care Unit
HDU / Step-Down Unit
Day Surgery / Ambulatory
Ward / Floor
Estimated length of stay: _____ days
Post-Op Pain Management:
PCA (Patient-Controlled Analgesia)
Epidural analgesia
Peripheral nerve catheter
Multimodal analgesia (IV/PO)
Regional block (single-shot)
APS (Acute Pain Service) consult
OPTIMIZATION REQUIRED / RECOMMENDATIONS: None, patient optimized Yes (see below)
Medical Optimization:
Cardiac clearance / Cardiology consult
Pulmonary optimization / Respirology consult
Glycemic control / Endocrine consult
Hematology consult (bleeding/coagulation)
Nephrology consult (renal function)
Further investigations needed: _______________________________________________
Medication adjustment: _____________________________________________________
Other: ____________________________________________________________________
Additional Comments / Special Considerations:
_____________________________________________________________________________________________
_____________________________________________________________________________________________
SECTION 11: PRE-OPERATIVE INSTRUCTIONS
NPO (Nil Per Os / Fasting) INSTRUCTIONS:
Standard adult fasting: Solids ≥8 hours, Clear fluids ≥2 hours
Modified fasting: Solids ≥____ hrs, Clear fluids ≥____ hrs
NPO from: Solids: ________ (date/time) / Clears: ________ (date/time)

Medications to CONTINUE on day of surgery:
_________________________________________________

Medications to HOLD on day of surgery:
_________________________________________________
Pre-Medication Orders:
Midazolam ___mg PO/IV
Acetaminophen ___mg PO
Gabapentin ___mg PO
Famotidine/PPI ___mg PO
Antibiotic prophylaxis: ________
Other: ___________________

Special Instructions:
Bring CPAP machine
Bring inhalers
Other: ___________________
ANESTHESIA CONSENT & DISCUSSION:

I have discussed the anesthesia plan, risks, benefits, and alternatives with the patient/substitute decision-maker. Questions were answered. The patient/SDM understands and consents to the proposed anesthetic technique.

Risks discussed: Dental injury Sore throat N/V Awareness Aspiration Nerve injury PDPH Cardiac Stroke Death Other: __________

Anesthesiologist Name (Print)

Signature

Date

Time

Pre-Induction Comprehensive Checklist

MUST BE COMPLETED BEFORE SHIFTING PATIENT & STARTING ANESTHESIA

Patient Addressograph
(Name, MRN, DOB)
⚠ ALL ITEMS MUST BE CHECKED "YES" OR "N/A" BEFORE PROCEEDING TO ANESTHESIA ⚠
Date: _____________ Time: _____________ Location: Holding Area OR
SECTION 1: PATIENT IDENTIFICATION & CONSENT (IPSG.1 - CBAHI/JCI)
Item Verified By
1.1 Patient identity confirmed using TWO identifiers (Name + MRN or DOB)
1.2 Patient identification band present and matches medical record
1.3 Patient confirms planned procedure and surgical site (verbal if conscious)
1.4 Surgical consent signed, dated, and matches scheduled procedure
1.5 Anesthesia consent signed and risks discussed with patient/family
1.6 Surgical site marked by surgeon (if laterality/level applicable) N/A
1.7 Blood transfusion consent obtained (if anticipated) N/A
SECTION 2: ALLERGIES & CRITICAL MEDICAL INFORMATION
Item Details / N/A
2.1 Allergies reviewed and documented (including drug, latex, food)
2.2 Allergy band applied if applicable NKDA
2.3 Pre-anesthesia assessment reviewed (ASA, airway, risk factors) ASA: I II III IV V E
2.4 Any NEW symptoms or changes since pre-op clinic?
(chest pain, SOB, infection, pregnancy test)
No Yes: ___________
2.5 Recent illness / URTI screened (last 2 weeks)? No Yes: ___________
SECTION 3: NPO STATUS & ASPIRATION RISK
Item Documentation
3.1 NPO instructions followed? Last Solid Food: _______ hrs ago
Last Clear Liquids: _______ hrs ago
3.2 NPO guidelines met?
(Solids ≥6h, Clear fluids ≥2h, Breast milk ≥4h)
Yes No → Discussed with surgeon
3.3 Aspiration risk assessed?
(GERD, hiatal hernia, bowel obstruction, full stomach)
Low Risk High Risk → RSI planned
SECTION 4: MEDICATION RECONCILIATION (IPSG.4 - CBAHI/JCI)
Item Action / Time
4.1 Home medications reviewed (especially cardiac, diabetes, anticoagulants) Confirmed N/A
4.2 Cardiac/antihypertensive medications taken today? Yes No N/A
4.3 Diabetes medications managed? (insulin held/adjusted) Yes N/A | BG: _____ mg/dL
4.4 Anticoagulants/antiplatelets held per protocol? Yes, held _____ days ago N/A
4.5 Herbal/supplements discontinued ≥7 days? Yes N/A
4.6 Premedication administered (if ordered)? Drug: _________ Dose: _____ Time: _____ N/A
4.7 Prophylactic antibiotic ordered and ready? Drug: _________ Dose: _____ N/A
SECTION 5: VITAL SIGNS & PRE-OPERATIVE ASSESSMENT
Item Values / Status
5.1 Vital signs documented within last hour BP: ___/___ HR: ___ RR: ___ SpO2: ___% Temp: ___°C
5.2 Baseline vitals acceptable for surgery? Yes No → Discussed with team
5.3 Oxygen requirement documented Room Air O2 at _____ L/min via _____
5.4 Level of consciousness documented Alert Sedated Other: _____
SECTION 6: LABORATORY & DIAGNOSTIC RESULTS
Item Results / N/A
6.1 Required lab results available and reviewed? Yes N/A
6.2 CBC (Hb/Plt) reviewed if indicated Hb: _____ g/dL Plt: _____ N/A
6.3 Coagulation profile (INR/PTT) if indicated INR: _____ PTT: _____ N/A
6.4 Electrolytes/Renal function if indicated Na: ___ K: ___ Cr: ___ N/A
6.5 Pregnancy test (females 12-55 yrs) documented Negative Positive N/A
6.6 ECG/CXR/Echo reviewed if indicated Normal Abnormal: _____ N/A
6.7 Imaging studies available in OR if required Yes N/A
SECTION 7: AIRWAY ASSESSMENT & EQUIPMENT READINESS
Item Status
7.1 Airway examination reviewed (Mallampati, TMD, neck mobility) MP: I/II/III/IV TMD: >/<6cm Neck: Full/Limited
7.2 Dentition checked (loose teeth, caps, dentures removed) Good Risk: ________
7.3 Difficult airway identified? No YES → Equipment ready
7.4 Difficult airway cart available if needed? Yes N/A
7.5 Video laryngoscope/Fiberoptic available if needed? Yes N/A
SECTION 8: VASCULAR ACCESS & BLOOD MANAGEMENT
Item Status
8.1 IV access patent and functional Gauge: _____ Site: _______ None (to start in OR)
8.2 Additional IV access planned if needed? Yes, _____ lines N/A
8.3 Arterial line/CVC planned if indicated? A-line CVC N/A
8.4 Blood type & screen completed if indicated? Blood Type: _______ N/A
8.5 Blood products cross-matched and available if needed? Yes, _____ units G&S only N/A
8.6 Massive transfusion protocol discussed if high-risk case? Yes N/A
SECTION 9: ANESTHESIA PLAN & SPECIAL REQUIREMENTS
Item Plan
9.1 Anesthesia technique confirmed with patient GA Regional MAC Combined
9.2 Regional anesthesia equipment prepared if applicable Spinal kit Epidural Nerve block N/A
9.3 Postoperative pain management plan discussed PCA Epidural IV/PO Nerve block
9.4 PONV risk assessed and prophylaxis planned? Risk: Low Moderate High | Rx: _______
9.5 VTE prophylaxis applied (if ordered)? SCDs TED stockings N/A
9.6 Temperature management plan (warming devices) Forced air warmer Fluid warmer N/A
9.7 Special positioning equipment available? Yes: __________ N/A
9.8 Latex allergy precautions if applicable? Yes, latex-free setup N/A
9.9 ICU/HDU bed reserved if required? ICU HDU PACU only
9.10 Postoperative ventilation planned if needed? Yes No
SECTION 10: OPERATING ROOM READINESS (Before Patient Transfer)
Item Status
10.1 OR room prepared and ready for patient YES
10.2 Anesthesia machine checked (ABC check completed) YES
10.3 Monitoring equipment functional (ECG, NIBP, SpO2, Capnography) YES
10.4 Suction tested and working YES
10.5 Emergency drugs available (ephedrine, atropine, succinylcholine, epinephrine) YES
10.6 Anesthetic drugs prepared and labeled YES
10.7 IV fluids and blood warmer ready YES
10.8 Defibrillator in OR and functional YES
10.9 Surgeon present in OR area or immediately available YES
10.10 Surgical team briefing completed / WHO checklist ready YES
FINAL AUTHORIZATION TO PROCEED:

I have completed this comprehensive checklist. All items are verified and any concerns have been addressed. The patient is ready to be transferred to the OR and proceed with anesthesia.


Anesthesiologist Name (Print)

Signature

Date

Time

Pre-Op Nurse Signature

OR Circulating Nurse Signature

Pre-Anesthesia Safety Checklist

"Sign In" - Before Induction of Anesthesia

Patient Addressograph
(Name, MRN, DOB)

To be completed by Anesthesiologist & Circulating Nurse PRIOR to induction (CBAHI / JCI IPSG Compliant)

STOP CHECK: PATIENT & PROCEDURE
1. Patient Identity Confirmed? (Two identifiers: Name & MRN/DOB) YES
2. Surgical Site Marked? (If applicable, does mark match consent?) YES N/A
3. Consent Form Signed & Verified? (Procedure, Anesthesia, Blood) YES
4. Patient Allergies Checked? YES
ANESTHESIA SAFETY CHECKS
5. Anesthesia Safety Machine Check Completed? (ABC check) YES
6. Medication & Emergency Drugs Available? (Labelled correctly) YES
7. Pulse Oximetry & Monitors Functional?
(SpO2, NIBP, ECG, Capnography ready)
YES
8. Does the patient have a Difficult Airway / Aspiration Risk? NO
YES -> Equip Available
9. Risk of Massive Blood Loss (>500ml or 7ml/kg in peds)? NO
YES -> IV/Fluids Planned
10. Blood Products Verified? (If indicated) YES N/A
Team Briefing / Special Considerations:

Anesthesiologist (Signature/ID)

Circulating Nurse (Signature/ID)

Time Out Verified